Ayesha Siddiqui from BioSpectrum Asia spoke with our CEO and Co-Founder Choon-Peng (Choon) Ng about the progress around cancer research in Asia for her recent piece. See what Choon had to say in the full piece linked below....
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full...
Are you attending the 41st Annual JPM Healthcare Conference in San Francisco next month? Our CEO, Choon-Peng Ng, and Dan MacLeod, VP Discovery, will be on-site January 9-10th. We look forward to connecting with industry peers, sharing insights, and discussing...
Andreas Wilm, Director of Computational Biology and Lorenz Gerber, Associate Director of Software Engineering at ImmunoScape contributed a blog post for Amazon Web Services (AWS) to share how we were able to build an agile drug discovery pipeline with scalable compute...
